EPIX News and Press, ESSA Pharma Inc. From 08/18/21

Gainers: PharmaCyte Biotech (NASDAQ:PMCB) +118%. Virpax Pharmaceuticals (NASDAQ:VRPX) +59%. SGOCO Group (NASDAQ:SGOC) +53%. AzurRx BioPharma (NASDAQ:AZRX) +30%. NRx Pharmaceuticals (NASDAQ:NRXP) +26%. Standard Lithium (NYSE:SLI) +21%. ESSA Pharma (NASDAQ:EPIX) +15%. Agrify (NASDAQ:AGFY) +17%....

Worries about regulation have swirled lately around both Big Tech and Chinese stocks. These conspired to drag down a specific segment of the Chinese tech market on Monday, as China-based electric vehicle stocks took a tumble. XPeng (NYSE:XPEV), Li Auto (NASDAQ:LI) and NIO (NYSE:NIO) all lost ...

Gainers: NanoVibronix (NASDAQ:NAOV) +47%. Enlivex Therapeutics (NASDAQ:ENLV) +20%. GoHealth (NASDAQ:GOCO) +16%. Travere Therapeutics (NASDAQ:TVTX) +16%. Collegium Pharmaceutical (NASDAQ:COLL) +16%. Auddia (NASDAQ:AUUD) +15%. AudioEye (NASDAQ:AEYE) +14%. Cohen & Company (NYSE:COHN) +14%. F...

Gainers: NanoVibronix NAOV +44%, Nymox Pharmaceutical (NASDAQ:NYMX) +21%, Travere Therapeutics TVTX +20%, Enlivex Therapeutics ENLV +15%, Collegium Pharmaceutical COLL +11%. Losers: Sesen Bio SESN -35%, ESSA Pharma EPIX -32...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2021 Canada NewsWire HOUSTON, Texas and VANCOUVER, Canada , Aug. 16, 2021 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical...

Having reached a two-week low in the middle of the week, healthcare stocks in the S&P 500 rose two consecutive sessions to gain ~0.5% over the past five days. Yet, that was not enough to edge past the ~0.7% weekly gain in the broader index. Most healthcare stocks with the sharpest mo...

ESSA Pharma to Present at the Jefferies Virtual Healthcare Conference Canada NewsWire HOUSTON, Texas and VANCOUVER, Canada , May 25, 2021 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused o...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2021 Canada NewsWire - Presented promising preliminary pharmacokinetic and clinical data on EPI-7386 in metastatic castration-resistant prostate cancer at...

ESSA Pharma Announces Clinical Collaboration Agreement with Bayer to Evaluate the Combination of EPI-7386 and Darolutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire HOUSTON, Texas and VANCOUVER, Canada , April 28, 2021 /PRNe...

ESSA Pharma to Present at the Bloom Burton & Co. Healthcare Investor Conference ESSA Pharma to Present at the Bloom Burton & Co. Healthcare Investor Conference PR Newswire HOUSTON , Texas and VANCOUVER, Canada , April 14, 2021 /PRNewswire/ - ...